MedPath

Tele-spirometry in Primary Care-Randomized Clinical Trial Cluster:Telemedicine in Chronic Obstructive Pulmonary Disease

Not Applicable
Conditions
Chronic Obstructive Pulmonary Disease
Registration Number
NCT02901535
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

The purpose of this study is to determine the effectiveness of telemedicine multifaceted intervention in symptoms patients with chronic obstructive pulmonary disease.

Detailed Description

This study is a randomized clinical trial for patients with chronic obstructive pulmonary disease from a primary care. The purpose is to determine the effectiveness of telemedicine (teleconsultation and telemonitoring) in control of chronic obstructive pulmonary disease symptoms.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
240
Inclusion Criteria
  • spirometry from TelessaudeRS-Universidade Federal do Rio Grande do Sul (from randomization cluster), Modified Medical Research Council Dyspnea > 0
Exclusion Criteria
  • normal or restrictive spirometry, low quality spirometries (inadequate)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Symptoms20 a 22 weeks

Modified Medical Research Council Dyspnea Scale (difference in mMRC)

Secondary Outcome Measures
NameTimeMethod
Spirometry - FEV120 a 22 weeks

spirometry parameters - FEV 1 (forced expiratory volume in one second)

Spirometry - FVC20 a 22 weeks

spirometry parameters - FVC (forced vital capacity)

Trial Locations

Locations (1)

TelessaudeRS-Universidade Federal do Rio Grande do Sul

🇧🇷

Porto Alegre, Rio Grande do Sul, Brazil

TelessaudeRS-Universidade Federal do Rio Grande do Sul
🇧🇷Porto Alegre, Rio Grande do Sul, Brazil
Cynthia G Molina-Bastos, MD
Contact
5191322585
cyncarol@gmail.com
Marcelo R. Gonçalves, PhD
Contact
5191175156
marcelorog@gmail.com
Maria Angela F Moreira, PhD
Sub Investigator
Dimitris V Rados, Msc
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.